tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TAK Stock Latest News

Takeda Completes Share Repurchase Program in May 2025
Company AnnouncementsTakeda Completes Share Repurchase Program in May 2025
20h ago
6K
TAK
Takeda Defends Leadership Amid Shareholder Voting Recommendations
PremiumCompany Announcements
Takeda Defends Leadership Amid Shareholder Voting Recommendations
7d ago
6K
TAK
Takeda reports EC approves Adcetris combination for Hodgkin lymphoma
PremiumThe Fly
Takeda reports EC approves Adcetris combination for Hodgkin lymphoma
10d ago
TAK
Positive Outlook for Takeda Pharmaceutical Co: Buy Rating Supported by Promising Phase 3 Data and Projected Sales for Rusfertide
PremiumRatings
Positive Outlook for Takeda Pharmaceutical Co: Buy Rating Supported by Promising Phase 3 Data and Projected Sales for Rusfertide
11d ago
TAK
Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint
PremiumThe Fly
Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint
11d ago
TAK
PTGX
Veeva price target raised to $300 from $270 at Needham
PremiumThe FlyVeeva price target raised to $300 from $270 at Needham
15d ago
CRM
TAK
Takeda Reports Changes in Subsidiaries and Associates as of May 28, 2025
Premium
Company Announcements
Takeda Reports Changes in Subsidiaries and Associates as of May 28, 2025
16d ago
6K
TAK
Takeda Announces CEO Succession and Advocates for Healthcare Reforms
Premium
Company Announcements
Takeda Announces CEO Succession and Advocates for Healthcare Reforms
16d ago
6K
TAK
Takeda Reports Strong FY2024 Performance and Executive Compensation Strategy
PremiumCompany Announcements
Takeda Reports Strong FY2024 Performance and Executive Compensation Strategy
16d ago
6K
TAK
Takeda Announces 149th Annual General Meeting of Shareholders
PremiumCompany Announcements
Takeda Announces 149th Annual General Meeting of Shareholders
16d ago
6K
TAK
Takeda Pharmaceutical Co: Balancing Challenges and Opportunities Amid US Tariffs and Pricing Uncertainties
PremiumRatings
Takeda Pharmaceutical Co: Balancing Challenges and Opportunities Amid US Tariffs and Pricing Uncertainties
18d ago
TAK
Takeda Pharmaceutical: Resilient Growth and Strong Sales Ambition Justify Buy Rating
PremiumRatings
Takeda Pharmaceutical: Resilient Growth and Strong Sales Ambition Justify Buy Rating
23d ago
TAK
Veeva has ‘meaningful’ Life Science head start over Salesforce, says Oppenheimer
PremiumThe FlyVeeva has ‘meaningful’ Life Science head start over Salesforce, says Oppenheimer
24d ago
CRM
TAK
Takeda publishes oveporexton data in New England Journal of Medicine
Premium
The Fly
Takeda publishes oveporexton data in New England Journal of Medicine
29d ago
TAK
Takeda Pharmaceutical Reports April 2025 Share Repurchase Progress
Premium
Company Announcements
Takeda Pharmaceutical Reports April 2025 Share Repurchase Progress
30d ago
6K
TAK
Takeda’s Earnings Call Highlights Growth Amid Challenges
PremiumCompany Announcements
Takeda’s Earnings Call Highlights Growth Amid Challenges
1M ago
TAK
Takeda Pharmaceutical Reports Strong Growth Amid Challenges
PremiumCompany Announcements
Takeda Pharmaceutical Reports Strong Growth Amid Challenges
1M ago
TAK
Novavax announces improved terms for nuvaxovid agreement with Takeda in Japan
PremiumThe Fly
Novavax announces improved terms for nuvaxovid agreement with Takeda in Japan
1M ago
TAK
NVAX
CHMP gives positive opinion on variation to marketing authorization for Adcetris
PremiumThe Fly
CHMP gives positive opinion on variation to marketing authorization for Adcetris
2M ago
TAK
Takeda Completes Significant Share Repurchase in March 2025
PremiumCompany AnnouncementsTakeda Completes Significant Share Repurchase in March 2025
2M ago
6K
TAK
Takeda upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Takeda upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
TAK
Takeda Canada says Health Canada expands marketing authorization for HyQvia
Premium
The Fly
Takeda Canada says Health Canada expands marketing authorization for HyQvia
3M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >